Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians

Abstract EN

Drug-induced hematological cytopenia is common in kidney transplantation.

Various cytopenia including leucopenia (neutropenia), thrombocytopenia, and anemia can occur in kidney transplant recipients.

Persistent severe leucopenia or neutropenia can lead to opportunistic infections of various etiologies.

On the contrary, reducing or stopping immunosuppressive medications in these events can provoke a rejection.

Transplant clinicians are often faced with the delicate dilemma of balancing cytopenia and rejection from adjustments of immunosuppressive regimen.

Differentials of drug-induced cytopenia are wide.

Identification of culprit medication and subsequent modification is also challenging.

In this review, we will discuss individual drug implicated in causing cytopenia and correlate it with corresponding literature evidence.